"10.1371_journal.pone.0026568","plos one","2011-10-25T00:00:00Z","Peter Joseph Jongen; Christian Sindic; Evert Sanders; Stanley Hawkins; Wim Linssen; Erik van Munster; Stephan Frequin; George Borm; and the Functional composite and quality of Life in Avonex-treated Relapsing multiple sclerosis patients (FLAIR) Study Group","MS4 Research Institute, Nijmegen, The Netherlands; Service de Neurologie, Cliniques Universitaires St. Luc U.C.L., Brussels, Belgium; Department of Neurology, Amphia Hospital, Breda, The Netherlands; Northern Ireland Regional Neurology Service, Royal Victoria Hospital, Belfast, Northern Ireland, United Kingdom; Department of Neurology, St. Lucas Andreas Ziekenhuis, Amsterdam, The Netherlands; Department of Neurology, Jeroen Bosch Ziekenhuis, s-Hertogenbosch, The Netherlands; Department of Neurology, St. Antonius Ziekenhuis, Nieuwegein, The Netherlands; Department of Epidemiology, Biostatistics and HTA, Radboud University Nijmegen Medical Centre, Nijmegen, The Netherlands","Conceived and designed the experiments: PJJ CS ES. Performed the experiments: PJJ CS ES SH WL EvM SF. Analyzed the data: PJJ GB. Wrote the paper: PJJ CS ES WL GB.","The authors have the following competing interests. This study was funded by Biogen-Idec. Dr. Jongen has received honoraria from Sanofi-Aventis, Teva, Merck-Serono, Novartis, Bayer-Schering, Biogen-Idec and Allergan for activities as speaker, advisory committee member, research support, or travel grants for conferences. Dr. Jongen had full access to all of the data in this study and takes complete responsibility for the integrity of the data and the accuracy of the data analysis. There are no patents, products in development or marketed products to declare. This does not alter the authors adherence to all the PLoS ONE policies on sharing data and materials, as detailed online in the guide for authors.","2011","10","Peter Joseph Jongen","PJJ",9,TRUE,NA,NA,NA,NA,NA,NA,NA,NA,NA
